Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 cases

AIM: To present results of the keratoprosthesis method used at The Filatov Institute of Eye Diseases and Tissue Therapy.METHODS: A retrospective case series analysis was used to describe the development of new types of keratoprostheses and methods of implantation as well as different ways of leukoma...

Full description

Bibliographic Details
Main Author: Stanislav Iakymenko
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2013-06-01
Series:International Journal of Ophthalmology
Subjects:
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693023/
_version_ 1811318426267811840
author Stanislav Iakymenko
author_facet Stanislav Iakymenko
author_sort Stanislav Iakymenko
collection DOAJ
description AIM: To present results of the keratoprosthesis method used at The Filatov Institute of Eye Diseases and Tissue Therapy.METHODS: A retrospective case series analysis was used to describe the development of new types of keratoprostheses and methods of implantation as well as different ways of leukoma strengthening.RESULTS: Keratoprosthesis was performed in 1 060 eyes of 1 040 patients with leukomas of different etiology: burns, 725 eyes (68.4%); trauma, 120 eyes (11.3%); keratitis and ocular pemphigoid, 108 eyes (10.2%); and bullous keratopathy, 107 eyes (10.1%). Visual acuity before keratoprosthesis consisted of light perception in 962 eyes (92%), and 98 eyes (8%) had minimal visual acuity (1/200-1/50). Both eyes were blind (visual acuity less than 1/200) in 955 patients (91.8%). The period of blindness varied from 1 to 52 years. As a result of keratoprosthesis, visual acuity of ≥1/200 was restored in 1 023 of 1 060 eyes (96.5%). Visual acuity of 20/200-20/20 was achieved in 716 eyes (67.5%). At the last follow-up visit visual acuity of ≥1/200 was preserved in 806 eyes (76%), visual acuity of 20/200-20/20 was measured in 583 of 1 060 eyes (55%) and good keratoprosthesis fixation in the cornea was achieved in 986 of 1 060 eyes (93%). The minimal follow-up was 12 months (range, 12 months to 37 years, median 5 years).CONCLUSION: Our techniques of keratoprosthesis effectively restore vision in patients with leukomas that cannot be treated by optical corneal grafting.
first_indexed 2024-04-13T12:26:07Z
format Article
id doaj.art-4c4f9efeb9cb49d09ab1d11fffae7b91
institution Directory Open Access Journal
issn 2222-3959
2227-4898
language English
last_indexed 2024-04-13T12:26:07Z
publishDate 2013-06-01
publisher Press of International Journal of Ophthalmology (IJO PRESS)
record_format Article
series International Journal of Ophthalmology
spelling doaj.art-4c4f9efeb9cb49d09ab1d11fffae7b912022-12-22T02:47:02ZengPress of International Journal of Ophthalmology (IJO PRESS)International Journal of Ophthalmology2222-39592227-48982013-06-016337538010.3980/j.issn.2222-3959.2013.03.22Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 casesStanislav IakymenkoAIM: To present results of the keratoprosthesis method used at The Filatov Institute of Eye Diseases and Tissue Therapy.METHODS: A retrospective case series analysis was used to describe the development of new types of keratoprostheses and methods of implantation as well as different ways of leukoma strengthening.RESULTS: Keratoprosthesis was performed in 1 060 eyes of 1 040 patients with leukomas of different etiology: burns, 725 eyes (68.4%); trauma, 120 eyes (11.3%); keratitis and ocular pemphigoid, 108 eyes (10.2%); and bullous keratopathy, 107 eyes (10.1%). Visual acuity before keratoprosthesis consisted of light perception in 962 eyes (92%), and 98 eyes (8%) had minimal visual acuity (1/200-1/50). Both eyes were blind (visual acuity less than 1/200) in 955 patients (91.8%). The period of blindness varied from 1 to 52 years. As a result of keratoprosthesis, visual acuity of ≥1/200 was restored in 1 023 of 1 060 eyes (96.5%). Visual acuity of 20/200-20/20 was achieved in 716 eyes (67.5%). At the last follow-up visit visual acuity of ≥1/200 was preserved in 806 eyes (76%), visual acuity of 20/200-20/20 was measured in 583 of 1 060 eyes (55%) and good keratoprosthesis fixation in the cornea was achieved in 986 of 1 060 eyes (93%). The minimal follow-up was 12 months (range, 12 months to 37 years, median 5 years).CONCLUSION: Our techniques of keratoprosthesis effectively restore vision in patients with leukomas that cannot be treated by optical corneal grafting.http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693023/artificial corneacorneal graftingkeratoprosthesisleukoma
spellingShingle Stanislav Iakymenko
Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 cases
International Journal of Ophthalmology
artificial cornea
corneal grafting
keratoprosthesis
leukoma
title Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 cases
title_full Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 cases
title_fullStr Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 cases
title_full_unstemmed Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 cases
title_short Forty-five years of keratoprosthesis study and application at the Filatov Institute: a retrospective analysis of 1 060 cases
title_sort forty five years of keratoprosthesis study and application at the filatov institute a retrospective analysis of 1 060 cases
topic artificial cornea
corneal grafting
keratoprosthesis
leukoma
url http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693023/
work_keys_str_mv AT stanislaviakymenko fortyfiveyearsofkeratoprosthesisstudyandapplicationatthefilatovinstitutearetrospectiveanalysisof1060cases